200 related articles for article (PubMed ID: 18359426)
1. Impact of inappropriate antibiotic therapy on mortality in patients with ventilator-associated pneumonia and blood stream infection: a meta-analysis.
Kuti EL; Patel AA; Coleman CI
J Crit Care; 2008 Mar; 23(1):91-100. PubMed ID: 18359426
[TBL] [Abstract][Full Text] [Related]
2. Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients?
Eachempati SR; Hydo LJ; Shou J; Barie PS
J Trauma; 2009 May; 66(5):1343-8. PubMed ID: 19430237
[TBL] [Abstract][Full Text] [Related]
3. Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: an observational, multicenter study comparing monotherapy with combination antibiotic therapy.
Garnacho-Montero J; Sa-Borges M; Sole-Violan J; Barcenilla F; Escoresca-Ortega A; Ochoa M; Cayuela A; Rello J
Crit Care Med; 2007 Aug; 35(8):1888-95. PubMed ID: 17581492
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for treatment failure in patients with ventilator-associated pneumonia receiving appropriate antibiotic therapy.
Gursel G; Aydogdu M; Ozyilmaz E; Ozis TN
J Crit Care; 2008 Mar; 23(1):34-40. PubMed ID: 18359419
[TBL] [Abstract][Full Text] [Related]
5. Bacteremia in patients with ventilator-associated pneumonia is associated with increased mortality: A study comparing bacteremic vs. nonbacteremic ventilator-associated pneumonia.
Agbaht K; Diaz E; Muñoz E; Lisboa T; Gomez F; Depuydt PO; Blot SI; Rello J
Crit Care Med; 2007 Sep; 35(9):2064-70. PubMed ID: 17581489
[TBL] [Abstract][Full Text] [Related]
6. Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections: impact of delayed appropriate antibiotic selection.
Lodise TP; Patel N; Kwa A; Graves J; Furuno JP; Graffunder E; Lomaestro B; McGregor JC
Antimicrob Agents Chemother; 2007 Oct; 51(10):3510-5. PubMed ID: 17646415
[TBL] [Abstract][Full Text] [Related]
7. Predictors of mortality in adult patients with ventilator-associated pneumonia: a meta-analysis.
Siempos II; Vardakas KZ; Kyriakopoulos CE; Ntaidou TK; Falagas ME
Shock; 2010 Jun; 33(6):590-601. PubMed ID: 19953007
[TBL] [Abstract][Full Text] [Related]
8. Attributable mortality of ventilator-associated pneumonia: a meta-analysis.
Agrafiotis M; Siempos II; Ntaidou TK; Falagas ME
Int J Tuberc Lung Dis; 2011 Sep; 15(9):1154-63, i-v. PubMed ID: 21669028
[TBL] [Abstract][Full Text] [Related]
9. C-reactive protein correlates with bacterial load and appropriate antibiotic therapy in suspected ventilator-associated pneumonia.
Lisboa T; Seligman R; Diaz E; Rodriguez A; Teixeira PJ; Rello J
Crit Care Med; 2008 Jan; 36(1):166-71. PubMed ID: 18007271
[TBL] [Abstract][Full Text] [Related]
10. Administration of antimicrobials via the respiratory tract for the treatment of patients with nosocomial pneumonia: a meta-analysis.
Ioannidou E; Siempos II; Falagas ME
J Antimicrob Chemother; 2007 Dec; 60(6):1216-26. PubMed ID: 17934205
[TBL] [Abstract][Full Text] [Related]
11. Impact of superinfection on hospital length of stay and costs in patients with ventilator-associated pneumonia.
Eagye KJ; Nicolau DP; Kuti JL
Semin Respir Crit Care Med; 2009 Feb; 30(1):116-23. PubMed ID: 19199193
[TBL] [Abstract][Full Text] [Related]
12. Ventilator-associated pneumonia: breaking the vicious circle of antibiotic overuse.
Leone M; Garcin F; Bouvenot J; Boyadjev I; Visintini P; Albanèse J; Martin C
Crit Care Med; 2007 Feb; 35(2):379-85; quizz 386. PubMed ID: 17205011
[TBL] [Abstract][Full Text] [Related]
13. Inadequate treatment of ventilator-associated pneumonia: risk factors and impact on outcomes.
Teixeira PJ; Seligman R; Hertz FT; Cruz DB; Fachel JM
J Hosp Infect; 2007 Apr; 65(4):361-7. PubMed ID: 17350721
[TBL] [Abstract][Full Text] [Related]
14. [Duration of antibiotic therapy for ventilator-associated pneumonia: comparison of 7 and 10 days. A pilot study].
Fekih Hassen M; Ayed S; Ben Sik Ali H; Gharbi R; Marghli S; Elatrous S
Ann Fr Anesth Reanim; 2009 Jan; 28(1):16-23. PubMed ID: 19097848
[TBL] [Abstract][Full Text] [Related]
15. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
Deal EN; Micek ST; Reichley RM; Ritchie DJ
Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
[TBL] [Abstract][Full Text] [Related]
16. Aminoglycoside treatment and mortality after bacteraemia in patients given appropriate empirical therapy: a Danish hospital-based cohort study.
Freundlich M; Thomsen RW; Pedersen L; West H; Schønheyder HC
J Antimicrob Chemother; 2007 Nov; 60(5):1115-23. PubMed ID: 17881632
[TBL] [Abstract][Full Text] [Related]
17. Predictors and outcomes of antibiotic adequacy for bloodstream infections in veterans with spinal cord injury.
Evans CT; Burns SP; Chin A; Weaver FM; Hershow RC
Arch Phys Med Rehabil; 2009 Aug; 90(8):1364-70. PubMed ID: 19651270
[TBL] [Abstract][Full Text] [Related]
18. Ventilator-associated pneumonia: an overview.
DiCocco JM; Croce MA
Expert Opin Pharmacother; 2009 Jun; 10(9):1461-7. PubMed ID: 19505213
[TBL] [Abstract][Full Text] [Related]
19. Infections in a surgical intensive care unit of a university hospital in Greece.
Markogiannakis H; Pachylaki N; Samara E; Kalderi M; Minettou M; Toutouza M; Toutouzas KG; Theodorou D; Katsaragakis S
Int J Infect Dis; 2009 Mar; 13(2):145-53. PubMed ID: 18775663
[TBL] [Abstract][Full Text] [Related]
20. Topical chlorhexidine for prevention of ventilator-associated pneumonia: a meta-analysis.
Chlebicki MP; Safdar N
Crit Care Med; 2007 Feb; 35(2):595-602. PubMed ID: 17205028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
